Literature DB >> 2714616

Methods for analyzing and interpreting cooperativity in dose-response curves--I. Antagonist effects on angiotensin receptors in smooth muscle.

G J Moore1, M N Scanlon.   

Abstract

1. Dose-response curves for angiotensins II and III in the rat isolated uterus, portal vein and aorta, in the absence and presence of the antagonist [Sar1Ile8]ANG II, have been analyzed by methods which detect cooperativity. 2. Hanes-Woolf transformations of dose-response data were used to define phases of positive homotropic cooperativity, and this information was applied to the interpretation of Hill plots. 3. The level of positive cooperativity was found to be higher for ANG II (nH = 1.35-2.00) than ANG III (nH = 1.02-1.43) in the three tissues studied. 4. In the presence of the antagonist [Sar1Ile8]ANG II a decrease in the level of cooperativity produced by both agonists was observed, and high concentrations of the antagonist could induce negative cooperativity. 5. These findings have been interpreted on the basis of a 2-site agonist binding mechanism involving receptor dimers, in which angiotensin agonists induce an increase in their own receptor binding affinity, whereas the antagonist [Sar1Ile8]ANG II decreases the affinity of angiotensin receptors for ANG II and ANG III.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714616     DOI: 10.1016/0306-3623(89)90014-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies.

Authors:  Atsushi Miyamoto; Ryoko Wada; Aya Inoue; Shigeru Ishiguro; James K Liao; Akira Nishio
Journal:  Life Sci       Date:  2005-10-11       Impact factor: 5.037

2.  Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts.

Authors:  Amarnath Talasila; Renée Germack; John M Dickenson
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

3.  Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.

Authors:  Graham J Moore; Harry Ridgway; Konstantinos Kelaidonis; Christos T Chasapis; Irene Ligielli; Thomas Mavromoustakos; Joanna Bojarska; John M Matsoukas
Journal:  Molecules       Date:  2022-07-29       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.